Wildflower Expands Nationwide Retail Presence with Dillard’s Department Stores
VANCOUVER, British Columbia, June 17, 2019- Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF) (the “Company”) is pleased to announce that it has received and fulfilled an opening purchase order from Dillard’s department stores that will place Wildflower wellness products in Dillard’s stores across the US.
Wildflower’s premium hemp CBD infused products can now be seen throughout 292 Dillard’s locations across the U.S. and the company’s retail presence throughout the country continues to expand. Rooted in transparency and best practices, Wildflower is looking forward to entering new key markets such as Florida and Texas to educate new consumers on salable products in the region. Wildflower has received subsequent purchase orders from Dillard’s and is fulfilling orders as they are received.
Wildflower CEO William Maclean says,“Launching into Dillard’s will double the number of retail locations we are in overnight. Our strategy is to build off our established brand equity in these key markets that can catapult us into becoming a household name. Dillard’s has the respect and reputation as a retailer that fits in with our loyal following. I am looking forward to bringing the wellness and health benefits of CBD through Wildflower’s products to Dillard’s clientele.”
Wildflower Brands is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of our brands work in synergy, toward becoming a global wellness leader.
Investor Relations Contact:
Will Elston, Investor Relations
Cautionary and Forward-Looking Statements
This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. Forward‐looking statements and information are often, but not always, identified by the use of words such as "appear", "seek", "anticipate", "plan", "continue", "estimate", "approximate", "expect", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe", "would" and similar expressions.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the risks associated with the marijuana industry in general such as operational risks in growing; competition; incorrect assessment of the value and potential benefits of various transactions; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and government regulations. Accordingly, readers should not place undue reliance on the forward‐looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
The Canadian Securities Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release.